american diabetes association 'history of pancreatitis' glp-1 receptor agonist glucagon-like peptide-1 agonists with cardiovascular and kidney outcomes in type 2 diabetic kidney transplant recipients | Cardiovascular Diabetology GLP-1 receptor agonists for individualized
Description
The litigation targets GLP-1 receptor agonist medications, a class of drugs originally developed for type 2 diabetes that became massively popular for weight loss
doi:10.1210/jcem.83.7.4877 127
Common Questions about GLP-1s vs
Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects
Substantial variability emerged among individual agents: exenatide demonstrated the longest median latency (54 days, IQR 16184), while dulaglutide showed the shortest (7 days, IQR 234)
Little information informs the potential actions of amylin in the human cardiovascular system
